×
S&P 500   3,890.16 (+1.17%)
DOW   31,299.64 (+0.84%)
QQQ   293.55 (+1.64%)
AAPL   145.41 (+1.74%)
MSFT   267.94 (+0.65%)
META   170.69 (+0.54%)
GOOGL   2,346.89 (+2.42%)
AMZN   116.03 (+1.49%)
TSLA   724.32 (+4.19%)
NVDA   157.32 (+3.98%)
NIO   22.23 (+6.72%)
BABA   123.02 (+3.27%)
AMD   78.85 (+4.64%)
MU   58.33 (+1.67%)
CGC   2.69 (+1.51%)
T   21.11 (+0.09%)
GE   62.33 (+1.23%)
F   11.53 (+4.25%)
DIS   96.96 (+0.92%)
AMC   13.63 (+8.43%)
PFE   53.01 (+0.49%)
PYPL   74.60 (+1.86%)
NFLX   188.82 (+2.59%)
S&P 500   3,890.16 (+1.17%)
DOW   31,299.64 (+0.84%)
QQQ   293.55 (+1.64%)
AAPL   145.41 (+1.74%)
MSFT   267.94 (+0.65%)
META   170.69 (+0.54%)
GOOGL   2,346.89 (+2.42%)
AMZN   116.03 (+1.49%)
TSLA   724.32 (+4.19%)
NVDA   157.32 (+3.98%)
NIO   22.23 (+6.72%)
BABA   123.02 (+3.27%)
AMD   78.85 (+4.64%)
MU   58.33 (+1.67%)
CGC   2.69 (+1.51%)
T   21.11 (+0.09%)
GE   62.33 (+1.23%)
F   11.53 (+4.25%)
DIS   96.96 (+0.92%)
AMC   13.63 (+8.43%)
PFE   53.01 (+0.49%)
PYPL   74.60 (+1.86%)
NFLX   188.82 (+2.59%)
S&P 500   3,890.16 (+1.17%)
DOW   31,299.64 (+0.84%)
QQQ   293.55 (+1.64%)
AAPL   145.41 (+1.74%)
MSFT   267.94 (+0.65%)
META   170.69 (+0.54%)
GOOGL   2,346.89 (+2.42%)
AMZN   116.03 (+1.49%)
TSLA   724.32 (+4.19%)
NVDA   157.32 (+3.98%)
NIO   22.23 (+6.72%)
BABA   123.02 (+3.27%)
AMD   78.85 (+4.64%)
MU   58.33 (+1.67%)
CGC   2.69 (+1.51%)
T   21.11 (+0.09%)
GE   62.33 (+1.23%)
F   11.53 (+4.25%)
DIS   96.96 (+0.92%)
AMC   13.63 (+8.43%)
PFE   53.01 (+0.49%)
PYPL   74.60 (+1.86%)
NFLX   188.82 (+2.59%)
S&P 500   3,890.16 (+1.17%)
DOW   31,299.64 (+0.84%)
QQQ   293.55 (+1.64%)
AAPL   145.41 (+1.74%)
MSFT   267.94 (+0.65%)
META   170.69 (+0.54%)
GOOGL   2,346.89 (+2.42%)
AMZN   116.03 (+1.49%)
TSLA   724.32 (+4.19%)
NVDA   157.32 (+3.98%)
NIO   22.23 (+6.72%)
BABA   123.02 (+3.27%)
AMD   78.85 (+4.64%)
MU   58.33 (+1.67%)
CGC   2.69 (+1.51%)
T   21.11 (+0.09%)
GE   62.33 (+1.23%)
F   11.53 (+4.25%)
DIS   96.96 (+0.92%)
AMC   13.63 (+8.43%)
PFE   53.01 (+0.49%)
PYPL   74.60 (+1.86%)
NFLX   188.82 (+2.59%)
NYSE:NTR

Nutrien Stock Forecast, Price & News

$76.93
+2.81 (+3.79%)
(As of 07/7/2022 12:03 PM ET)
Add
Compare
Today's Range
$75.79
$77.29
50-Day Range
$74.12
$107.31
52-Week Range
$57.08
$117.25
Volume
148,243 shs
Average Volume
3.66 million shs
Market Capitalization
$42.31 billion
P/E Ratio
9.88
Dividend Yield
2.62%
Price Target
$110.06

Nutrien MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.76 Rating Score
Upside/​Downside
42.9% Upside
$110.06 Price Target
Short Interest
Healthy
0.93% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-6.86
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
-8.56%
From $16.93 to $15.48 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.70 out of 5 stars

Basic Materials Sector

21st out of 247 stocks

Agricultural Chemicals Industry

3rd out of 12 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive NTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutrien and its competitors with MarketBeat's FREE daily newsletter.

Nutrien logo

About Nutrien (NYSE:NTR) Stock

Nutrien Ltd. provides crop inputs and services. It offers potash, nitrogen, phosphate, and sulfate products; and financial solutions. The company also distributes crop nutrients, crop protection products, seeds, and merchandise products through approximately 2,000 retail locations in the United States, Canada, South America, and Australia. In addition, it provides services directly to growers through a network of farm centers in North America, South America, and Australia. The company was founded in 2017 and is headquartered in Saskatoon, Canada.

NTR Stock News Headlines

Global Events Could Be A Boon For Potash Stocks (NTR)
Overall, the demand dynamics combined with the supply constraints bode well for potash stocks, which should benefit from higher margins and revenue. Consider the following potash stocks for your portfolio,
Global Events Could Be A Boon For Potash Stocks
Overall, the demand dynamics combined with the supply constraints bode well for potash stocks, which should benefit from higher margins and revenue. Consider the following potash stocks for your portfolio,
Nutrien (NYSE:NTR) Sees Strong Trading Volume
Nutrien Ltd. (NTR) To Go Ex-Dividend on June 29th
NTR vs. SQM: Which Stock Is the Better Value Option?
See More Headlines

Industry, Sector and Symbol

Industry
Agricultural chemicals
Sub-Industry
N/A
Employees
23,500
Year Founded
N/A

Company Calendar

Ex-Dividend for 4/14 Dividend
3/30/2022
Dividend Payable
4/14/2022
Last Earnings
5/02/2022
Ex-Dividend for 7/15 Dividend
6/29/2022
Today
7/07/2022
Dividend Payable
7/15/2022
Next Earnings (Confirmed)
8/03/2022
Fiscal Year End
12/31/2022

Price Target and Rating

Average Stock Price Forecast
$110.06
High Stock Price Forecast
$135.00
Low Stock Price Forecast
$73.00
Forecasted Upside/Downside
+43.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.76470588235294
Research Coverage
17 Analysts

Profitability

Net Income
$3.15 billion
Pretax Margin
19.21%

Debt

Sales & Book Value

Annual Sales
$27.71 billion
Cash Flow
$10.16 per share
Book Value
$42.44 per share

Miscellaneous

Free Float
532,975,000
Market Cap
$42.31 billion
Optionable
Optionable
Beta
0.95

Social Links















Nutrien Frequently Asked Questions

Should I buy or sell Nutrien stock right now?

17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 4 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Nutrien stock.
View analyst ratings for Nutrien
or view top-rated stocks.

What is Nutrien's stock price forecast for 2022?

17 analysts have issued 12 month price targets for Nutrien's shares. Their NTR stock forecasts range from $73.00 to $135.00. On average, they expect Nutrien's stock price to reach $110.06 in the next twelve months. This suggests a possible upside of 42.9% from the stock's current price.
View analysts' price targets for Nutrien
or view top-rated stocks among Wall Street analysts.

How has Nutrien's stock performed in 2022?

Nutrien's stock was trading at $75.20 at the beginning of 2022. Since then, NTR stock has increased by 2.4% and is now trading at $77.01.
View the best growth stocks for 2022 here
.

When is Nutrien's next earnings date?

Nutrien is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022.
View our earnings forecast for Nutrien
.

How can I listen to Nutrien's earnings call?

Nutrien will be holding an earnings conference call on Thursday, August 4th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Nutrien's earnings last quarter?

Nutrien Ltd. (NYSE:NTR) released its earnings results on Monday, May, 2nd. The company reported $2.70 EPS for the quarter, beating analysts' consensus estimates of $2.59 by $0.11. The business earned $7.66 billion during the quarter, compared to the consensus estimate of $7.77 billion. Nutrien had a trailing twelve-month return on equity of 20.55% and a net margin of 14.34%.
View Nutrien's earnings history
.

How often does Nutrien pay dividends? What is the dividend yield for Nutrien?

Nutrien announced a quarterly dividend on Friday, May 20th. Stockholders of record on Thursday, June 30th will be paid a dividend of $0.48 per share on Friday, July 15th. This represents a $1.92 dividend on an annualized basis and a yield of 2.49%. The ex-dividend date of this dividend is Wednesday, June 29th.
View Nutrien's dividend history
.

Is Nutrien a good dividend stock?

Nutrien(NYSE:NTR) pays an annual dividend of $1.96 per share and currently has a dividend yield of 2.62%. Nutrien has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio of Nutrien is 25.16%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Nutrien will have a dividend payout ratio of 12.66% next year. This indicates that Nutrien will be able to sustain or increase its dividend.
View Nutrien's dividend history.

What guidance has Nutrien issued on next quarter's earnings?

Nutrien issued an update on its FY 2022 earnings guidance on Monday, May, 9th. The company provided EPS guidance of $16.20-$18.70 for the period, compared to the consensus earnings per share estimate of $14.73. The company issued revenue guidance of -.

Who are Nutrien's key executives?

Nutrien's management team includes the following people:
  • Mr. Kenneth A. Seitz, Interim Pres & CEO (Age 52, Pay $1.71M)
  • Mr. Pedro Farah, Exec. VP & CFO
  • Ms. Noralee M. Bradley, Exec. VP & Chief Legal Officer
  • Mr. Raef M. Sully, Exec. VP and CEO of Phosphate & Nitrogen (Age 55, Pay $1.51M)
  • Mr. Brent D. Poohkay, Exec. VP & Chief Information Officer (Age 52)
  • Jeff Holzman, VP of Investor Relations
  • Megan Fielding, VP of Brand & Culture Communications
  • Ms. Candace Laing, Sr. VP & Chief HR Officer
  • Dr. Stephen Francis Dowdle Ph.D., Pres of PCS Sales (Age 71)
  • Jason Newton, Head Economist

What other stocks do shareholders of Nutrien own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

What is Nutrien's stock symbol?

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Who are Nutrien's major shareholders?

Nutrien's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Parsec Financial Management Inc. (0.02%).

Which institutional investors are selling Nutrien stock?

NTR stock was sold by a variety of institutional investors in the last quarter, including Parsec Financial Management Inc..

How do I buy shares of Nutrien?

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nutrien's stock price today?

One share of NTR stock can currently be purchased for approximately $77.01.

How much money does Nutrien make?

Nutrien (NYSE:NTR) has a market capitalization of $42.35 billion and generates $27.71 billion in revenue each year. The company earns $3.15 billion in net income (profit) each year or $7.79 on an earnings per share basis.

How many employees does Nutrien have?

Nutrien employs 23,500 workers across the globe.

How can I contact Nutrien?

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The official website for Nutrien is www.nutrien.com. The company can be reached via phone at (306) 933-8500, via email at investors@nutrien.com, or via fax at 306-933-8877.

This page (NYSE:NTR) was last updated on 7/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.